Direct-to-Consumer Genetic Testing: Global Markets and Technologies

Report Code: MDS008B

Publish Date: Nov 2024

Publisher: BCC Publishing

Category: Medical Devices And Surgical

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

Report Includes

  • 18 data tables and 27 additional tables
  • An overview of the global market and technologies for Direct-to-Consumer Genetic Testing
  • Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market size and prospects for revenue growth, accompanied by a market share analysis by product type, and region
  • Forecast of future trends, including regulatory challenges, review of patents, ESG trends and emerging technologies
  • Market share analysis of the key companies in the industry and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other strategies
  • Profiles of the major players, including Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs, and Color Health

Report Scope

The report analyzes the market for DTC genetic testing, offering a look at the competitive landscape and the leading companies’ revenues, product portfolios and recent developments. The report analyzes trends and market dynamics, including drivers, limitations, challenges and opportunities. It assesses current and potential market size, in order to help industry executives make informed decisions about the production and licensing of goods and services. The study segments the market on the basis of segment/application type, such as ancestry, health and lifestyle. The health market segment is analyzed by technology and by disease category (cancer, cardiovascular, complex common, pharmacogenomics, rare diseases and others). The lifestyle market segment is segmented by technology and application (genetic relatedness, nutrigenomics, personal traits, weight management/fitness and others).

Regional market analysis is provided for all the major segments. The report covers tests that are directly ordered by consumers and consumer-initiated, physician-monitored tests. The DTC genetic testing of animals is outside the scope of the report. Regional market analysis is provided for all the major segments, and this includes some country-level analysis.

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS) and genotyping microarrays.

In this report, the market is divided into the following segments:

Market applications:

  • Ancestry.
  • Health.
  • Lifestyle.

Technologies:

  • Genotyping arrays.
  • Whole genome sequencing (WGS).
  • Whole exome sequencing (WES).
  • Polymerase chain reaction (PCR).
  • Targeted sequencing.

For each segment, current products are identified for the base year of 2023, the current market size is measured and market drivers identified, forecasts are made for 2029, and the current market shares of companies are assessed.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $2.1 billion
Market size forecast $3.7 billion
Growth rate CAGR of 10.0% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Product Type, and Region
Regions covered North America, Europe, Asia-Pacific, Latin America, Rest of the World
Countries covered U.S., Canada, Mexico, Germany, France, U.K., Spain, Italy, China, India, Japan, Brazil, Argentina, and Chile
Key Market Drivers
  • Increased access to genetic testing due to low cost of genomic sequencing.
  • Aggressive marketing.
  • Preference for pharmacogenomic testing based on DTC genetic testing.
  • Growing prevalence of chronic diseases, such as cancer and diabetes.
Companies studied
23ANDME INC.ANCESTRY
COLOR HEALTH INC.DANTE LABS GLOBAL
MYHERITAGE LTD.MYDNA LIFE AUSTRALIA PTY LTD.
PRIVAPATH DIAGNOSTICS
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global DTC genetic testing market is projected to grow from $2.1 billion in 2023 to $3.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.0% during the forecast period.
The market is mainly driven by people’s increasing curiosity about their ancestral roots and their desire for personalized health insights. These insights help individuals assess their risk of developing diseases such as cancer, diabetes, and cardiovascular diseases, allowing them to make more informed health decisions. The market is also growing due to the easy accessibility of these tests and the strong marketing efforts by companies, which boost consumer interest and drive market expansion.
The DTC GT testing market is segmented based on the application type, technology type and by geographic regions.
The Ancestry segment will dominate the market by the end of 2029.
North America holds the highest share in the market.

Analyst Credentials

Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Direct-to-Consumer Genetic Testing: Global Markets and Technologies84Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview13Free
Chapter- 3: Market Dynamics9Free
Chapter- 4: Emerging Technologies and Developments4Free
Chapter- 5: DTC Genetic Testing Market22Free
Chapter- 6: Competitive Intelligence2Free
Chapter- 7: Sustainability in the DTC Genetic Testing Industry: An ESG Perspective6Free
Chapter- 8: Patent Analysis7Free
Chapter- 9: Appendix16Free
Published - Dec-2020| Analyst - John Bergin| Code - MDS008A

Report Highlights

The global DTC genetic testing market should grow from $1.2 billion in 2020 to $2.7 billion by 2025 with a compound annual growth rate (CAGR) of 17.7% for the period of 2020-2025.

Report Inludes

  • 12 data tables and 39 additional tables
  • An overview of the global markets and technologies for direct to consumer (DTC) genetic testing
  • Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Information on key genomic regions associated with genetic testing and description of instruments and technologies used for DTC genetic testing
  • Coverage of DNA sequencing; microarray; and software industries and description of the key initiatives in the genetic testing industry
  • Detailed analysis of the current market trends, market forecast and discussion of technological, regulatory and competitive elements as well as economic trends affecting the future marketplace for direct to consumer (DTC) genetic testing and impact analysis of COVID-19 on the market
  • Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry
  • Profiles of the key companies in the DTC testing industry, including Chendu 23Mofang Biotechnology Co. Ltd (23Mofand), Genetic Technologies Ltd, Illumina Inc., Myriad Genetics Inc., Thermo Fisher Scientific Inc., and Quest Diagnostics Inc.

Related Reports

Direct-to-Consumer Testing Industry: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC269B

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Recent Reports

Direct-to-Consumer Genetic Testing: Global Markets and Technologies

Published - Nov 2024 | Publisher - Gundreddy Gopinadh | Code - MDS008B

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

Global Medical Tapes Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - MDS105A

The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.

Global Prenatal Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS103A

The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.

Global Skin Allergy Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS104A

The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.

Global Orthodontic and Orthopedic Market

Published - Apr 2024 | Publisher - Partha Sarathi Das | Code - MDS036B

The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes

Top Trending Reports

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
Sample Report